Arrowstreet Capital Limited Partnership grew its holdings in shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD – Free Report) by 163.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 52,227 shares of the company’s stock after purchasing an additional 32,378 shares during the period. Arrowstreet Capital Limited Partnership owned approximately 0.22% of Tactile Systems Technology worth $895,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Jones Financial Companies Lllp acquired a new position in Tactile Systems Technology during the fourth quarter worth $39,000. 1620 Investment Advisors Inc. purchased a new position in shares of Tactile Systems Technology in the 4th quarter valued at about $97,000. AlphaQuest LLC purchased a new position in shares of Tactile Systems Technology in the 4th quarter valued at about $158,000. XTX Topco Ltd acquired a new stake in shares of Tactile Systems Technology in the third quarter valued at about $163,000. Finally, Retireful LLC purchased a new stake in Tactile Systems Technology during the fourth quarter worth about $173,000. 83.43% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research analysts have issued reports on the stock. StockNews.com cut shares of Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 29th. B. Riley downgraded Tactile Systems Technology from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $23.00 to $18.00 in a research note on Wednesday, February 19th.
Tactile Systems Technology Price Performance
Tactile Systems Technology stock opened at $13.27 on Friday. The firm has a market capitalization of $314.05 million, a PE ratio of 18.96 and a beta of 1.21. Tactile Systems Technology, Inc. has a 52 week low of $11.12 and a 52 week high of $21.10. The firm’s 50-day simple moving average is $14.47 and its 200 day simple moving average is $15.75. The company has a quick ratio of 3.80, a current ratio of 4.36 and a debt-to-equity ratio of 0.11.
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last announced its quarterly earnings results on Tuesday, February 18th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.09. Tactile Systems Technology had a net margin of 5.79% and a return on equity of 9.37%. The company had revenue of $85.59 million for the quarter, compared to the consensus estimate of $85.39 million. On average, equities research analysts predict that Tactile Systems Technology, Inc. will post 0.7 EPS for the current fiscal year.
Insider Buying and Selling at Tactile Systems Technology
In other Tactile Systems Technology news, Director Daniel L. Reuvers sold 10,938 shares of the company’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $14.55, for a total value of $159,147.90. Following the transaction, the director now directly owns 242,942 shares in the company, valued at approximately $3,534,806.10. This represents a 4.31 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Elaine M. Birkemeyer sold 3,778 shares of the firm’s stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $14.70, for a total transaction of $55,536.60. Following the sale, the chief financial officer now directly owns 104,098 shares in the company, valued at $1,530,240.60. This represents a 3.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 19,546 shares of company stock worth $285,444. 0.96% of the stock is owned by insiders.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Recommended Stories
- Five stocks we like better than Tactile Systems Technology
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- 3 Stocks to Consider Buying in October
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- How to Invest in the FAANG Stocks
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.